Liensinine attenuates inflammation and oxidative stress in spleen tissue in an LPS-induced mouse sepsis model. 2023

Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
Jiangsu Key Laboratory of Marine Bioresources and Environment, Co-Innovation Center of Jiangsu Marine Bio-industry Technology, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China.

Sepsis is a complex syndrome caused by multiple pathogens and involves multiple organ failure, particularly spleen dysfunction. In 2017, the worldwide incidence was 48.9 million sepsis cases and 11 million sepsis-related deaths were reported (Rudd et al., 2020). Inflammation, oxidative stress, and apoptosis are the most common pathologies seen in sepsis. Liensinine (LIE) is a bisbenzylisoquinoline-type alkaloid extracted from the seed embryo of Nelumbo nucifera. Lotus seed hearts have high content of LIE which mainly has antihypertensive and antiarrhythmic pharmacological effects. It can exert anti-carcinogenic activity by regulating cell, inflammation, and apoptosis signaling pathways (Manogaran et al., 2019). However, its protective effect from sepsis-induced spleen damage is unknown. In this research, we established a mouse sepsis model induced by lipopolysaccharide (LPS) and investigated the protective effects of LIE on sepsis spleen injury in terms of inflammatory response, oxidative stress, and apoptosis.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D018805 Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. Bloodstream Infection,Pyaemia,Pyemia,Pyohemia,Blood Poisoning,Poisoning, Blood,Septicemia,Severe Sepsis,Blood Poisonings,Bloodstream Infections,Infection, Bloodstream,Poisonings, Blood,Pyaemias,Pyemias,Pyohemias,Sepsis, Severe,Septicemias

Related Publications

Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
January 2024, International immunopharmacology,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
February 2022, Cell death & disease,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
September 2023, International immunopharmacology,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
January 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
January 2018, Oxidative medicine and cellular longevity,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
January 2016, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
December 2023, International immunopharmacology,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
November 2018, International immunopharmacology,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
November 2023, Pathology, research and practice,
Hanyu Wang, and Yuanhao Yang, and Xiao Zhang, and Yan Wang, and Hui Fan, and Jinfeng Shi, and Xuelian Tan, and Baoshi Xu, and Jingchao Qiang, and Enzhuang Pan, and Mingyi Chu, and Zibo Dong, and Jingquan Dong
April 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!